Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma

Figure 2 Predictive value of plasma miR-21 and miR-93 for radiotherapy and chemotherapy efficacy in esophageal squamous cell carcinoma patients. A: Expression of plasma miR-21 in esophageal squamous cell carcinoma (ESCC) patients before and after radiotherapy and chemotherapy; B: Expression of plasma miR-93 in ESCC patients before and after radiotherapy and chemotherapy; C: Expression of plasma miR-21 in ESCC patients with effective and ineffective response to radiotherapy and chemotherapy; D: Expression of plasma miR-93 in ESCC patients with effective and ineffective response to radiotherapy and chemotherapy; E: Receiver operating characteristic curves of plasma miR-21 and miR-93 for assessing radiotherapy and chemotherapy efficacy before radiotherapy and chemotherapy. ^bP < 0.01 vs control group.